High on innovation, rising demand and rejuvenated confidence to translate opportunities into success, the Indian pharmaceutical industry, which is among the top three in terms of volume globally, is growing leaps and bounds. By an estimate, the industry is all set to expand at a Compound Annual Growth Rate (CAGR) of 16 per cent to $55 billion by 2020. Much of this growth will depend on Indian pharma companies’ capacity to adopt Information Technology to drive their productivity, improve efficiency and maintain cost effectiveness.

In view of increased digital adoption, it is expected that Healthcare Information Technology (IT) market would expand more than 1.5 times by 2020 from its current value of $1 billion to meet the demand from pharma industry as well as other vertical of the healthcare sector….[Read More]

KEY SPEAKERS

Future Pharma For One World! Be a Global Leader in the Pharma

Past Partners in our Summits

eHealth 2016 Conferences Videos

Social Footprints

6790+
Facebook Likes
6200+
Linkedin Followers
1710+
Twitter Followers
80+
Our Conferences

Powered By

RSS Latest on eHEALTH Pharma

  • NPPA caps prices of 30 more essential drugs
    The National Pharmaceutical Pricing Authority (NPPA) has fixed ceiling price of 30 more essential drugs, bringing about 760 medicines under price control in India. “All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus local taxes as applicable) so […]
  • Suven Life Sciences begins phase 1 clinical trial of MDD drug
    Pharma company Suven Life Sciences Ltd on Wednesday announced that it has initiated phase 1 development and first dosing of their NCESUVN-911, a potent, selective, brain penetrant and orally active, novel chemical entity intended for the treatment of major depressive disorder (MDD). “Progression of SUVN-911 into phase 1 clinical development is a significant achievement in […]
  • GNH India imports life-saving rare tumour drug to India
    GNH India, one of India’s leading pharmaceutical wholesalers, has successfully imported a life-saving ‘Orphan’ drug — named so as it is not easily available globally — which is used to fight solid tumours and soft tissue sarcomas. The medicine, Olaratumab (trade name Lartruvo), is a monoclonal antibody developed by Eli Lilly and Company is directed […]
  • Lupin gets CDSCO nod for 2nd generation antihistanine medicine
    The Central Drugs Standard Control Organisation (CDSCO) has given its approval to Mumbai-based multinational pharmaceutical company Lupin Limited for Bepotastine tablets — a new generation of antihistanine medicine that has been found more effective in controlling day time and night time triggers of allergic symptoms. Lupin will commence promoting the drug in India soon, the […]
  • Dr. Reddy’s gets USFDA approval for anti-cancer injection
    Dr. Reddy’s has received an approval from US Food and Drug Administration (USFDA) for the launch of Doxorubicin Hydrochloride Liposome injection, a therapeutic equivalent generic version of Doxil that is used by patients of ovarian cancer and Kaposi sarcoma after treatment with chemotherapy. “This approval represents the first of its kind for Dr. Reddy’s in […]

Know More About Pharma CIO 2017